SMI 8'304 -0.7%  Dow 19'827 -0.3%  Nikkei 18'814 -1.5%  Euro 1.0730 0.1% 
SPI 9'069 -0.6%  EStoxx50 3'285 -0.3%  Gold 1'217 0.3%  Dollar 1.0017 -0.9% 
DAX 11'540 -0.1%  FTSE100 7'220 -1.5%  Öl 55.5 -0.3%  Pfund 1.2419 2.1% 

Biomarin Pharmaceutical Aktie [Valor: 729021 / ISIN: US09061G1013]

Kaufen
Verkaufen

Als führende Anbieterin von Online-Finanzdienstleistungen bietet Swissquote Bank AG eine benutzerfreundliche Trading Plattform für den Handel von über 2.5 Millionen Finanzprodukten. Hinzu kommen verschiedene Forex Plattformen, ePrivate Banking Services, Hypotheken und Sparkonten.

Kaufen
Verkaufen
Konto eröffnen

Analysen zu Biomarin Pharmaceutical Inc.

08.12.16 Biomarin Pharmaceutical Buy Gabelli & Co
03.11.16 Biomarin Pharmaceutical Buy Deutsche Bank AG
08.04.16 Biomarin Pharmaceutical Outperform BMO Capital Markets
08.03.16 Biomarin Pharmaceutical Outperform Robert W. Baird & Co. Incorporated
03.03.16 Biomarin Pharmaceutical Buy Stifel, Nicolaus & Co., Inc.
29.02.16 Biomarin Pharmaceutical Neutral Wedbush Morgan Securities Inc.
26.02.16 Biomarin Pharmaceutical Outperform RBC Capital Markets
25.11.15 Biomarin Pharmaceutical Perform Oppenheimer & Co. Inc.
08.07.15 Biomarin Pharmaceutical Outperform RBC Capital Markets
19.06.15 Biomarin Pharmaceutical Neutral Robert W. Baird & Co. Incorporated
18.06.15 Biomarin Pharmaceutical Buy Deutsche Bank AG
18.06.15 Biomarin Pharmaceutical Buy Canaccord Adams
18.06.15 Biomarin Pharmaceutical Outperform RBC Capital Markets
05.06.15 Biomarin Pharmaceutical overweight Barclays Capital
27.03.15 Biomarin Pharmaceutical Buy UBS AG
27.03.15 Biomarin Pharmaceutical Buy Deutsche Bank AG
19.12.14 Biomarin Pharmaceutical Outperform RBC Capital Markets
11.12.14 Biomarin Pharmaceutical Buy UBS AG
25.11.14 Biomarin Pharmaceutical Outperform RBC Capital Markets
24.10.14 Biomarin Pharmaceutical Outperform RBC Capital Markets
06.11.12 Biomarin Pharmaceutical outperform RBC Capital Markets
03.09.12 Biomarin Pharmaceutical outperform RBC Capital Markets
28.08.12 Biomarin Pharmaceutical hold Deutsche Bank Securities
23.07.12 Biomarin Pharmaceutical outperform RBC Capital Markets
22.06.12 Biomarin Pharmaceutical outperform RBC Capital Markets
01.06.12 Biomarin Pharmaceutical outperform RBC Capital Markets
17.02.12 Biomarin Pharmaceutical outperform RBC Capital Markets
13.02.12 Biomarin Pharmaceutical outperform RBC Capital Markets
12.12.11 Biomarin Pharmaceutical buy Citigroup Corp.
08.12.11 Biomarin Pharmaceutical buy Citigroup Corp.
07.12.11 Biomarin Pharmaceutical buy Jefferies & Company Inc.
29.09.11 Biomarin Pharmaceutical buy Deutsche Bank Securities
25.10.10 Biomarin Pharmaceutical neutral Wedbush Morgan Securities Inc.
17.08.10 Biomarin Pharmaceutical neutral Wedbush Morgan Securities Inc.
16.04.10 Biomarin Pharmaceutical kaufen Der Aktionär
29.10.09 Biomarin Pharmaceutical outperform Credit Suisse Group
22.10.09 Biomarin Pharmaceutical buy Citigroup Corp.
19.10.09 Biomarin Pharmaceutical hold ROTH Capital Partners, LLC
08.10.09 Biomarin Pharmaceutical buy Jefferies & Company Inc.
03.08.09 Biomarin Pharmaceutical neutral Wedbush Morgan Securities Inc.
31.07.09 Biomarin Pharmaceutical buy Jefferies & Company Inc.
27.07.09 Biomarin Pharmaceutical buy ROTH Capital Partners, LLC
31.03.09 Biomarin Pharmaceutical market weight Thomas Weisel Partners LLC
27.03.09 Biomarin Pharmaceutical neutral Piper Jaffray & Co.
12.03.09 Biomarin Pharmaceutical outperform Leerink Swann LLC
12.03.09 Biomarin Pharmaceutical buy FTN Midwest Securities Corp.
24.02.09 Biomarin Pharmaceutical buy ROTH Capital Partners, LLC
23.02.09 Biomarin Pharmaceutical buy Jefferies & Company Inc.
19.02.09 Biomarin Pharmaceutical neutral Credit Suisse Group
19.02.09 Biomarin Pharmaceutical market perform Wachovia Securities, LLC
Seite: 1 | 2

Eintrag hinzufügen

Aktuelle Aktienanalysen
17.01.17 Metro-Goldwyn-Mayer Outperform Telsey Advisory Group
17.01.17 Chiasma Underweight Barclays Capital
17.01.17 Buckeye Partners L PPartnership Units Equal weight Barclays Capital
17.01.17 Yahoo buy UBS AG
17.01.17 Amazoncom buy UBS AG
17.01.17 eBay buy UBS AG
17.01.17 Facebook buy UBS AG
17.01.17 Kratos Defense & Security Solutions Buy Canaccord Adams
17.01.17 K+S buy Commerzbank AG
17.01.17 DEUTZ kaufen DZ BANK
17.01.17 Twitter Neutral UBS AG
17.01.17 SpartanNash Company Hold Pivotal Research Group
17.01.17 Noble Energy Neutral Seaport Global Securities
17.01.17 Zalando kaufen DZ BANK
17.01.17 International Seaways Buy Seaport Global Securities
17.01.17 Wirecard buy Baader Bank
17.01.17 General Electric (GE) buy Stifel, Nicolaus & Co., Inc.
17.01.17 McDonalds neutral Morgan Stanley
17.01.17 RATIONAL Hold Baader Bank
17.01.17 thyssenkrupp Sell UBS AG
17.01.17 Rio Tinto buy UBS AG
17.01.17 NORMA Group buy Baader Bank
17.01.17 CompuGroup Medical buy Baader Bank
17.01.17 Telefon AB LMEricsson (B) Neutral UBS AG
17.01.17 Nokia buy UBS AG
17.01.17 HOCHTIEF Sell Société Générale Group S.A. (SG)
17.01.17 METRO buy Baader Bank
17.01.17 HUGO BOSS kaufen Independent Research GmbH
17.01.17 LEG Immobilien buy Warburg Research
17.01.17 Beiersdorf Hold Baader Bank
17.01.17 Drägerwerk vz Halten DZ BANK
17.01.17 Trex Neutral Wedbush Morgan Securities Inc.
17.01.17 Rio Tinto Equal-Weight Morgan Stanley
17.01.17 Banco Bilbao Vizcaya Argentaria overweight Morgan Stanley
17.01.17 Banco Santander Central Hispano Equal-Weight Morgan Stanley
17.01.17 FUCHS PETROLUB accumulate equinet AG
17.01.17 International Consolidated Airlines Group overweight Morgan Stanley
17.01.17 Deutsche Post overweight Morgan Stanley
17.01.17 Deutsche Lufthansa Underweight Morgan Stanley
17.01.17 BP Hold Jefferies & Company Inc.
17.01.17 Exxon Mobil Hold Jefferies & Company Inc.
17.01.17 TOTAL Hold Jefferies & Company Inc.
17.01.17 Royal Dutch Shell (A) buy Jefferies & Company Inc.
17.01.17 Eni buy Jefferies & Company Inc.
17.01.17 Entravision Communications Neutral Wedbush Morgan Securities Inc.
17.01.17 Fabrinet Strong Buy Needham & Company, LLC
17.01.17 Ceragon Networks Hold Needham & Company, LLC
17.01.17 First Republic Bank Buy Maxim Group
17.01.17 AEterna Zentaris Buy Maxim Group
17.01.17 Nordstrom Hold Stifel, Nicolaus & Co., Inc.